Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$9.05 - $11.72 $64,209 - $83,153
7,095 New
7,095 $64,000
Q2 2023

Jul 18, 2023

BUY
$8.8 - $13.4 $38,667 - $58,879
4,394 Added 31.22%
18,470 $198,000
Q1 2023

Apr 13, 2023

BUY
$10.2 - $11.91 $56,354 - $65,802
5,525 Added 64.61%
14,076 $143,000
Q4 2022

Jan 23, 2023

SELL
$9.72 - $13.62 $2,080 - $2,914
-214 Reduced 2.44%
8,551 $0
Q3 2022

Oct 26, 2022

SELL
$11.82 - $15.42 $11,760 - $15,342
-995 Reduced 10.19%
8,765 $112,000
Q2 2022

Jul 25, 2022

BUY
$7.31 - $13.55 $1,228 - $2,276
168 Added 1.75%
9,760 $125,000
Q1 2022

May 02, 2022

SELL
$10.47 - $16.75 $12,605 - $20,167
-1,204 Reduced 11.15%
9,592 $100,000
Q4 2021

Jan 28, 2022

BUY
$15.36 - $25.0 $165,826 - $269,900
10,796 New
10,796 $166,000

Others Institutions Holding CGEM

About Cullinan Oncology, Inc.


  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $613M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.